Premium
P4–047: Energy inhibition elevates beta–secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: Possible early events in Alzheimer's disease pathogenesis
Author(s) -
Vassar Robert,
Velliquette Rodney A.,
O'Connor Tracy
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1785
Subject(s) - genetically modified mouse , medicine , amyloid precursor protein , endocrinology , pathogenesis , amyloid precursor protein secretase , transgene , chemistry , alzheimer's disease , pharmacology , disease , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom